These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 7749894

  • 41. Development and validation of gene therapies in autoimmune diseases: Epidemiology to animal models.
    Leung PS, Shu SA, Kenny TP, Wu PY, Tao MH.
    Autoimmun Rev; 2010 Mar; 9(5):A400-5. PubMed ID: 20035901
    [Abstract] [Full Text] [Related]

  • 42. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells.
    Ji Q, Goverman J.
    Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824
    [Abstract] [Full Text] [Related]

  • 43. Gene therapy in nonhuman primate models of human autoimmune disease.
    t'Hart BA, Vervoordeldonk M, Heeney JL, Tak PP.
    Gene Ther; 2003 May; 10(10):890-901. PubMed ID: 12732874
    [Abstract] [Full Text] [Related]

  • 44. VIP prevents experimental multiple sclerosis by downregulating both inflammatory and autoimmune components of the disease.
    Fernandez-Martin A, Gonzalez-Rey E, Chorny A, Martin J, Pozo D, Ganea D, Delgado M.
    Ann N Y Acad Sci; 2006 Jul; 1070():276-81. PubMed ID: 16888178
    [Abstract] [Full Text] [Related]

  • 45. Linkage analysis in multiple sclerosis of chromosomal regions syntenic to experimental autoimmune disease loci.
    Xu C, Dai Y, Lorentzen JC, Dahlman I, Olsson T, Hillert J.
    Eur J Hum Genet; 2001 Jun; 9(6):458-63. PubMed ID: 11436128
    [Abstract] [Full Text] [Related]

  • 46. The immunological basis for treatment of multiple sclerosis.
    Holmøy T, Vartdal F.
    Scand J Immunol; 2007 Oct; 66(4):374-82. PubMed ID: 17850581
    [Abstract] [Full Text] [Related]

  • 47. Autoimmune versus oligodendrogliopathy: the pathogenesis of multiple sclerosis.
    Nakahara J, Aiso S, Suzuki N.
    Arch Immunol Ther Exp (Warsz); 2010 Oct; 58(5):325-33. PubMed ID: 20676785
    [Abstract] [Full Text] [Related]

  • 48. Immunological aspects of multiple sclerosis.
    Hughes RA.
    Br J Hosp Med; 1977 Nov; 18(5):467-8, 470, 473-6. PubMed ID: 597658
    [No Abstract] [Full Text] [Related]

  • 49. [The significance of a B cell-dependent immunopathology in multiple sclerosis].
    Kuerten S, Pauly R, Blaschke S, Rottlaender A, Kaiser CC, Schroeter M, Fink GR, Addicks K.
    Fortschr Neurol Psychiatr; 2011 Feb; 79(2):83-91. PubMed ID: 21253995
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. The autoimmune pathogenesis of multiple sclerosis.
    Lehmann PV, Rottlaender A, Kuerten S.
    Pharmazie; 2015 Jan; 70(1):5-11. PubMed ID: 25975091
    [Abstract] [Full Text] [Related]

  • 52. Multiple sclerosis: geoepidemiology, genetics and the environment.
    Milo R, Kahana E.
    Autoimmun Rev; 2010 Mar; 9(5):A387-94. PubMed ID: 19932200
    [Abstract] [Full Text] [Related]

  • 53. Immunotherapeutics of multiple sclerosis.
    Durelli L.
    Acta Neurol (Napoli); 1991 Oct; 13(5):467-75. PubMed ID: 1723242
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Proceedings: Immunogenetic aspects of demyelinating disease.
    Arnason BG, Chelmicka-Szorc E.
    Neurology; 1975 May; 25(5):489. PubMed ID: 1079582
    [No Abstract] [Full Text] [Related]

  • 56. [Destruction of nerve cells cultured "in vitro" by lymphocytes from patients with multiple sclerosis. Auto-immune pathogenesis of multiple sclerosis].
    Halpern B, Bakouche P, Martial-Lasfargues C.
    Presse Med (1893); 1969 Dec 25; 77(55):2103-6. PubMed ID: 4190510
    [No Abstract] [Full Text] [Related]

  • 57. Genetics of multiple sclerosis.
    Sadovnick AD, Ebers GC.
    Neurol Clin; 1995 Feb 25; 13(1):99-118. PubMed ID: 7739507
    [Abstract] [Full Text] [Related]

  • 58. Down syndrome presenting with multiple sclerosis, thyroid dysfunction, and diabetes mellitus. Multiple autoimmune disorders in a genetic disorder.
    Nabavi SM, Hamzehloo A, Sabet Z.
    Neurosciences (Riyadh); 2011 Oct 25; 16(4):375-7. PubMed ID: 21983385
    [Abstract] [Full Text] [Related]

  • 59. Cyclosporine and multiple sclerosis: the cons.
    Rudge P.
    Neurology; 1988 Jul 25; 38(7 Suppl 2):29-30. PubMed ID: 3290712
    [Abstract] [Full Text] [Related]

  • 60. Suppression of the immune reaction in multiple sclerosis might be achieved by intravenous injections of myelin basic protein, concomitant with the administration of an immunosuppressant and a corticosteroid.
    Eidinoff H.
    Med Hypotheses; 1988 Apr 25; 25(4):219-22. PubMed ID: 2452965
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.